← Back to Search

Decision Aid for Thyroid Cancer

N/A
Recruiting
Led By Elizabeth G Grubbs
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years old or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying how well a patient decision aid works in supporting decision-making about cancer care for patients with medullary thyroid cancer and their caregivers.

Who is the study for?
This trial is for adults with medullary thyroid cancer and their caregivers. Participants must be able to communicate in English, and pregnant patients can join. It's also open to healthcare providers treating this condition. People with cognitive or psychological impairments are not eligible.
What is being tested?
The study is testing a decision aid designed to help patients and caregivers make informed choices about starting or stopping medications, joining clinical trials, or continuing with active monitoring of medullary thyroid cancer.
What are the potential side effects?
Since the intervention involves questionnaire administration and use of a decision aid, there are no direct medical side effects associated with typical drug treatments; however, participants may experience stress or emotional discomfort while making decisions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Decision aid acceptability
Decision aid design refining (storyboarding)
Needs assessment
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (decision aid)Experimental Treatment2 Interventions
Participants use decision aid and complete questionnaires.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,074 Previous Clinical Trials
1,803,227 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,957 Previous Clinical Trials
41,111,917 Total Patients Enrolled
Elizabeth G GrubbsPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
2,030 Total Patients Enrolled
Elizabeth G Grubbs, MDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Decision Aid Clinical Trial Eligibility Overview. Trial Name: NCT03892993 — N/A
Thyroid Cancer Research Study Groups: Supportive care (decision aid)
Thyroid Cancer Clinical Trial 2023: Decision Aid Highlights & Side Effects. Trial Name: NCT03892993 — N/A
Decision Aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT03892993 — N/A
~46 spots leftby Aug 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top